| P50 | author | Angel E. García | Q89238894 |
| P2093 | author name string | Chunyu Wang | |
| | David J Rosenman | |
| | Wen Chen | |
| | Christopher R Connors | |
| P2860 | cites work | Forecasting the global burden of Alzheimer’s disease | Q22252403 |
| | Electrostatics of nanosystems: application to microtubules and the ribosome | Q24555224 |
| | A series of PDB related databases for everyday needs | Q24613221 |
| | Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils | Q24631702 |
| | Atomic-Level Characterization of the Ensemble of the Aβ(1–42) Monomer in Water Using Unbiased Molecular Dynamics Simulations and Spectral Algorithms | Q24633954 |
| | Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory | Q24645499 |
| | Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences | Q24653927 |
| | The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study | Q24683781 |
| | The Alzheimer's peptide a beta adopts a collapsed coil structure in water | Q27626446 |
| | Stabilization of a -hairpin in monomeric Alzheimer's amyloid- peptide inhibits amyloid formation | Q27650192 |
| | Molecular structural basis for polymorphism in Alzheimer's -amyloid fibrils | Q27652925 |
| | Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features | Q27860675 |
| | NMRPipe: a multidimensional spectral processing system based on UNIX pipes | Q27860859 |
| | The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 |
| | GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation | Q27860944 |
| | Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra | Q27860984 |
| | PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations | Q27861014 |
| | Protein misfolding, functional amyloid, and human disease | Q28131732 |
| | Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide | Q28131750 |
| | Deciphering the genetic basis of Alzheimer's disease | Q28216056 |
| | Folding events in the 21-30 region of amyloid beta-protein (Abeta) studied in silico | Q28383620 |
| | Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils | Q28388148 |
| | Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide | Q28478284 |
| | A specific amyloid-beta protein assembly in the brain impairs memory | Q28854597 |
| | Knowledge-based protein secondary structure assignment | Q29547838 |
| | Why are "natively unfolded" proteins unstructured under physiologic conditions? | Q29615739 |
| | High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation | Q29616564 |
| | PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations | Q29617524 |
| | Self-consistent Karplus parametrization of 3J couplings depending on the polypeptide side-chain torsion chi1. | Q30328441 |
| | Structural differences between Abeta(1-40) intermediate oligomers and fibrils elucidated by proteolytic fragmentation and hydrogen/deuterium exchange | Q30437131 |
| | Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism | Q30873586 |
| | Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics | Q31047131 |
| | Structure and dynamics of the Abeta(21-30) peptide from the interplay of NMR experiments and molecular simulations | Q31152625 |
| | Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation | Q33196435 |
| | Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils | Q33307478 |
| | Predicting peptide structures in native proteins from physical simulations of fragments | Q33406232 |
| | Homogeneous and heterogeneous tertiary structure ensembles of amyloid-β peptides. | Q33973960 |
| | Hydrophobicity and conformational change as mechanistic determinants for nonspecific modulators of amyloid β self-assembly | Q34088492 |
| | Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways | Q34468169 |
| | Amyloid beta-protein assembly and Alzheimer disease | Q34849544 |
| | Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer. | Q35679065 |
| | Familial Alzheimer's disease mutations alter the stability of the amyloid beta-protein monomer folding nucleus | Q36082193 |
| | Discovery and structure activity relationship of small molecule inhibitors of toxic β-amyloid-42 fibril formation | Q36298522 |
| | Turn nucleation perturbs amyloid β self-assembly and cytotoxicity | Q36303460 |
| | The structure of Abeta42 C-terminal fragments probed by a combined experimental and theoretical study | Q37266611 |
| | Structure-neurotoxicity relationships of amyloid beta-protein oligomers | Q37329557 |
| | The biological significance of methionine sulfoxide stereochemistry | Q37809313 |
| | Simulations of the confinement of ubiquitin in self-assembled reverse micelles | Q41954509 |
| | On the nucleation of amyloid beta-protein monomer folding | Q42215600 |
| | The conformations of the amyloid-beta (21-30) fragment can be described by three families in solution | Q42597939 |
| | Structure of the 21-30 fragment of amyloid beta-protein. | Q43072330 |
| | Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains | Q43517947 |
| | Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease | Q44116115 |
| | A molecular switch in amyloid assembly: Met35 and amyloid beta-protein oligomerization | Q44685976 |
| | Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis | Q44700741 |
| | Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation | Q44769438 |
| | Amyloid beta-protein: monomer structure and early aggregation states of Abeta42 and its Pro19 alloform. | Q45266566 |
| | Comparing the folding free-energy landscapes of Abeta42 variants with different aggregation properties | Q45327298 |
| | Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide | Q45738154 |
| | Identification of physiological and toxic conformations in Abeta42 aggregates. | Q46179719 |
| | Solution NMR studies of Aβ monomer dynamics | Q46555702 |
| | Rapid photochemical cross-linking--a new tool for studies of metastable, amyloidogenic protein assemblies | Q47347367 |
| | Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). | Q48092766 |
| | Abeta40 inhibits amyloid deposition in vivo. | Q48305645 |
| | Characterizations of distinct amyloidogenic conformations of the Abeta (1-40) and (1-42) peptides | Q48330279 |
| | Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity | Q48394799 |
| | ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures | Q48530200 |
| | NMR: prediction of molecular alignment from structure using the PALES software | Q48590571 |
| | Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers. | Q50503231 |
| | 3D J-resolved NMR spectroscopy for unstructured polypeptides: fast measurement of 3J HNH alpha coupling constants with outstanding spectral resolution. | Q51745948 |
| | A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity. | Q53220934 |
| | A new structural model of Aβ40 fibrils. | Q53321830 |
| | M35 oxidation induces Abeta40-like structural and dynamical changes in Abeta42. | Q53392390 |
| | Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. | Q53648349 |
| | Distinct Morphologies for Amyloid Beta Protein Monomer: Aβ1–40, Aβ1–42, and Aβ1–40(D23N) | Q57835645 |
| | General Framework for Studying the Dynamics of Folded and Nonfolded Proteins by NMR Relaxation Spectroscopy and MD Simulation | Q59516092 |
| | Abeta40 protects non-toxic Abeta42 monomer from aggregation | Q80270099 |
| | Methyl dynamics of the amyloid-beta peptides Abeta40 and Abeta42 | Q80818596 |
| | Valence‐Bond Interpretation of Electron‐Coupled Nuclear Spin Interactions; Application to Methane | Q114767330 |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3338-3359 | |
| P577 | publication date | 2013-06-25 | |
| P1433 | published in | Journal of Molecular Biology | Q925779 |
| P1476 | title | Aβ monomers transiently sample oligomer and fibril-like configurations: ensemble characterization using a combined MD/NMR approach | |
| P478 | volume | 425 | |